JP2015529454A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529454A5
JP2015529454A5 JP2015524428A JP2015524428A JP2015529454A5 JP 2015529454 A5 JP2015529454 A5 JP 2015529454A5 JP 2015524428 A JP2015524428 A JP 2015524428A JP 2015524428 A JP2015524428 A JP 2015524428A JP 2015529454 A5 JP2015529454 A5 JP 2015529454A5
Authority
JP
Japan
Prior art keywords
nucleic acid
nme1
nme family
state
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015524428A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529454A (ja
JP6546087B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2012/060684 external-priority patent/WO2013059373A2/en
Application filed filed Critical
Priority claimed from PCT/US2013/051899 external-priority patent/WO2014018679A2/en
Publication of JP2015529454A publication Critical patent/JP2015529454A/ja
Publication of JP2015529454A5 publication Critical patent/JP2015529454A5/ja
Application granted granted Critical
Publication of JP6546087B2 publication Critical patent/JP6546087B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015524428A 2012-07-24 2013-07-24 Ｎｍｅバリアント種の発現および抑制 Expired - Fee Related JP6546087B2 (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201261675292P 2012-07-24 2012-07-24
US61/675,292 2012-07-24
US201261677442P 2012-07-30 2012-07-30
US61/677,442 2012-07-30
US201261679021P 2012-08-02 2012-08-02
US61/679,021 2012-08-02
US201261683155P 2012-08-14 2012-08-14
US61/683,155 2012-08-14
US201261684654P 2012-08-17 2012-08-17
US61/684,654 2012-08-17
US201261693712P 2012-08-27 2012-08-27
US61/693,712 2012-08-27
USPCT/US2012/060684 2012-10-17
PCT/US2012/060684 WO2013059373A2 (en) 2011-10-17 2012-10-17 Media for stem cell proliferation and induction
PCT/US2013/051899 WO2014018679A2 (en) 2012-07-24 2013-07-24 Nme variant species expression and suppression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019090368A Division JP2019141100A (ja) 2012-07-24 2019-05-13 Ｎｍｅバリアント種の発現および抑制

Publications (3)

Publication Number Publication Date
JP2015529454A JP2015529454A (ja) 2015-10-08
JP2015529454A5 true JP2015529454A5 (https=) 2016-09-15
JP6546087B2 JP6546087B2 (ja) 2019-07-17

Family

ID=49997968

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015524428A Expired - Fee Related JP6546087B2 (ja) 2012-07-24 2013-07-24 Ｎｍｅバリアント種の発現および抑制
JP2019090368A Pending JP2019141100A (ja) 2012-07-24 2019-05-13 Ｎｍｅバリアント種の発現および抑制
JP2021132192A Active JP7386210B2 (ja) 2012-07-24 2021-08-16 Ｎｍｅバリアント種の発現および抑制

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019090368A Pending JP2019141100A (ja) 2012-07-24 2019-05-13 Ｎｍｅバリアント種の発現および抑制
JP2021132192A Active JP7386210B2 (ja) 2012-07-24 2021-08-16 Ｎｍｅバリアント種の発現および抑制

Country Status (9)

Country Link
US (2) US20150203823A1 (https=)
EP (2) EP4206318A1 (https=)
JP (3) JP6546087B2 (https=)
CN (2) CN111849874A (https=)
AU (2) AU2013295811A1 (https=)
CA (1) CA2880010A1 (https=)
IL (1) IL236901B (https=)
SG (2) SG10201700593YA (https=)
WO (1) WO2014018679A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2686418A4 (en) 2011-03-17 2015-04-22 Minerva Biotechnologies Corp METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS
CN109456932A (zh) 2011-10-17 2019-03-12 米纳瓦生物技术公司 用于干细胞增殖和诱导的培养基
AU2014306778B2 (en) * 2013-08-12 2020-10-29 Minerva Biotechnologies Corporation Method for enhancing tumor growth
AU2015243948B2 (en) 2014-04-07 2020-10-15 Minerva Biotechnologies Corporation Anti-NME antibody
CN116199790A (zh) 2015-02-10 2023-06-02 米纳瓦生物技术公司 人源化抗MUCl*抗体
CN109081863A (zh) * 2018-08-01 2018-12-25 西北民族大学 抗癌活性物质放线菌素fgr的分离鉴定方法
EP3920693A4 (en) 2019-02-04 2022-10-05 Minerva Biotechnologies Corporation ANTI-NME ANTIBODIES AND METHODS OF TREATMENT OF CANCER OR CANCER METASTASIS
EP4161970A4 (en) 2020-06-08 2024-07-10 Minerva Biotechnologies Corporation ANTI-NME ANTIBODIES AND METHODS FOR TREATING CANCER OR CANCER METASTASES
CA3183682A1 (en) 2020-06-26 2021-12-30 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
CN119317447A (zh) 2022-04-12 2025-01-14 米纳瓦生物技术公司 抗可变muc1*抗体及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2329822A1 (en) * 2001-09-05 2011-06-08 Minerva Biotechnologies Corporation Compositions and methods of treatment of cancer
EP1375661A1 (en) * 2002-06-17 2004-01-02 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam The role of the N-myc - nm23H1/nm23H2 - cdc42 pathway in proliferation, differentiation and treatment of cancer
CN101273060A (zh) * 2005-06-24 2008-09-24 美国政府（由卫生和人类服务部、国立卫生研究院的部长所代表） 通过靶向肿瘤坏死因子受体的前配体装配域(plad)来缓解炎性关节炎
JP2008099662A (ja) * 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research 幹細胞の培養方法
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
US20090075926A1 (en) * 2006-12-06 2009-03-19 Bamdad Cynthia C Method for identifying and manipulating cells
WO2009012173A2 (en) 2007-07-13 2009-01-22 Dharmacon, Inc. Enhanced biotherapeutic production using inhibitory rna
CN102272290B (zh) * 2008-10-09 2018-08-14 米纳瓦生物技术公司 用于在细胞中诱导多能性的方法
MX2011013385A (es) * 2009-06-11 2012-05-29 Minerva Biotechnologies Corp Metodos para cultivar celulas madre y celulas progenitoras.
EP3228629A1 (en) * 2010-06-16 2017-10-11 Minerva Biotechnologies Corporation Reprogramming cancer cells
AU2013289913A1 (en) * 2012-07-13 2015-03-05 Minerva Biotechnologies Corporation Method for inducing cells to less mature state

Similar Documents

Publication Publication Date Title
JP2015529454A5 (https=)
Silva et al. Long noncoding RNAs: a missing link in osteoporosis
Silber et al. microRNAs in gliomas: small regulators of a big problem
AU2011311344B2 (en) Short RNA molecules
CN106978415B (zh) 转运rna片段及其应用
Ujigo et al. Administration of microRNA-210 promotes spinal cord regeneration in mice
Gagan et al. MicroRNAs regulate and provide robustness to the myogenic transcriptional network
Hunkler et al. Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration
Plowright et al. Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents
Takagi et al. IL-13 enhances mesenchymal transition of pulmonary artery endothelial cells via down-regulation of miR-424/503 in vitro
Kim et al. Recent advances in gene therapy for cardiac tissue regeneration
Lou et al. Current status of nucleic acid therapy and its new progress in cancer treatment
Bei et al. SR proteins in cancer: function, regulation, and small inhibitor
WO2013093870A1 (en) microRNAs FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION
JP2019509297A (ja) ヒト間葉系幹細胞（ｈＭＳＣ）からギャップジャンクションを介するオリゴ送達に基づく癌治療
Choong et al. The roles of non-coding RNAs in cardiac regenerative medicine
Dong et al. Non‐coding RNAs in cardiomyocyte proliferation and cardiac regeneration: Dissecting their therapeutic values
JPWO2011111824A1 (ja) マイクロｒｎａを用いた心筋細胞の増殖方法
JP7718819B2 (ja) 成体幹細胞の拡大と誘導のインビトロでの誘発
Hudson et al. The non-coding road towards cardiac regeneration
CN112843082B (zh) Dna四面体在制备治疗糖尿病的药物中的用途
CN104830863A (zh) 一种抑制FABP4基因表达的siRNA及其应用
CN102533755A (zh) 人miR-328反义核酸及其应用
Najmuddin et al. The linkage between microRNA and cancer and its delivery as cancer therapy: a mini-review
CN103405784B (zh) c-Fos基因在制备抗癌药物中的应用